FDA recalls antihistamine tablets. Here are the affected products.
Summary
The FDA announced a recall of a generic allergy medication made by Unique Pharmaceutical Laboratories because some tablets might be mixed with a heartburn drug called ranitidine. The recall affects certain lot numbers of cetirizine hydrochloride tablets distributed across the U.S. due to potential health risks for people sensitive to ranitidine.Key Facts
- Unique Pharmaceutical Laboratories is recalling generic cetirizine tablets, used for allergies.
- Some tablets showed discoloration or a red dot, suggesting contamination.
- The contaminant is ranitidine, a drug used for heartburn.
- Exposure to ranitidine can cause serious allergic reactions in sensitive people.
- No reports of health problems from the contaminated tablets have been made so far.
- The recalled products were sold in 100-tablet bottles under lot numbers expiring in October 2028.
- Rising Pharma Holdings distributed the recalled tablets and is arranging returns.
- Consumers can contact Rising Pharma Holdings or their healthcare providers with concerns.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
